Preclinical development of gene therapy for Parkinson's disease
Keywords: 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; 6-OHDA; 6-hydroxydopamine; AADC; aromatic l-amino acid decarboxylase; AAV; adeno-associated virus; AdV; adenovirus; BH4; tetrahydrobiopterin; CNS; central nervous system; D2; dopamine D2 receptor; GABA; γ-aminobutyric acid; GAD; glutamic acid decarboxyla